Omni Bio Pharmaceutical Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Liquidation
Omni Bio Pharmaceutical General Information
Description
Developer of biopharmaceutical products based in Greenwood Village, Colorado. The company focuses on discovering and developing therapeutic applications for the usage of protein alpha-1 antitrypsin, including in Type 1 diabetes, graft vs host disease, inflammation and infectious diseases, thereby aiming to accelerate repurposed drug use for unmet medical needs and clinical progression.
Contact Information
Website
www.omnibiopharma.comCorporate Office
- 5350 South Roslyn Street
- Suite 43
- Greenwood Village, CO 80111
- United States
Corporate Office
- 5350 South Roslyn Street
- Suite 43
- Greenwood Village, CO 80111
- United States
Omni Bio Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Bankruptcy: Liquidation | 08-May-2015 | Completed | Bankruptcy: Liquidation | |||
| 2. IPO | 21-Dec-2007 | Completed | Generating Revenue | |||
| 1. Later Stage VC | Completed | Generating Revenue |
Omni Bio Pharmaceutical Comparisons
Industry
Financing
Details
Omni Bio Pharmaceutical Competitors (25)
One of Omni Bio Pharmaceutical’s 25 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Amgen | Formerly PE-Backed | Thousand Oaks, CA |
Omni Bio Pharmaceutical Patents
Omni Bio Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2018100277-A | Compositions, methods and uses for alpha-1 antitrypsin fusion molecules | Active | 10-Jan-2012 | ||
| US-20140348859-A1 | Compositions, methods and uses for alpha-1 antitrypsin fusion molecules | Active | 10-Jan-2012 | ||
| WO-2013106589-A1 | Compositions, methods and uses for alpha-1 antitrypsin fusion molecules | Inactive | 10-Jan-2012 | ||
| JP-2017079769-A | Compositions, methods and uses for alfa-1 antitrypsin fusion molecules | Inactive | 24-Jun-2011 | ||
| EP-2723370-A2 | Compositions, methods and uses for alpha-1 antitrypsin fusion molecules | Inactive | 24-Jun-2011 | C07K16/40 |
Omni Bio Pharmaceutical Signals
Omni Bio Pharmaceutical Investments (1)
Omni Bio Pharmaceutical’s most recent deal was a Corporate with BioMimetix Pharmaceutical for . The deal was made on 21-Jul-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BioMimetix Pharmaceutical | 21-Jul-2011 | Corporate | Drug Discovery |
Omni Bio Pharmaceutical FAQs
-
When was Omni Bio Pharmaceutical founded?
Omni Bio Pharmaceutical was founded in 2006.
-
Where is Omni Bio Pharmaceutical headquartered?
Omni Bio Pharmaceutical is headquartered in Greenwood Village, CO.
-
What is the size of Omni Bio Pharmaceutical?
Omni Bio Pharmaceutical has 1 total employees.
-
What industry is Omni Bio Pharmaceutical in?
Omni Bio Pharmaceutical’s primary industry is Drug Discovery.
-
Is Omni Bio Pharmaceutical a private or public company?
Omni Bio Pharmaceutical is a Private company.
-
What is Omni Bio Pharmaceutical’s current revenue?
The current revenue for Omni Bio Pharmaceutical is .
-
Who are Omni Bio Pharmaceutical’s competitors?
Novartis, AbbVie, Gilead, Biocon, and Amgen are some of the 25 competitors of Omni Bio Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process